Connect with us

Technology

Disease Registry Innovations Propel Growth in USA Patient Registry Software Market

Published

on

DUBLIN, March 4, 2024 /PRNewswire/ — The USA Patient Registry Software Market Outlook to 2028″ report has been added to ResearchAndMarkets.com’s offering.

The latest comprehensive research publication offers valuable insights into the burgeoning USA Patient Registry Software market, highlighting significant growth within the sector driven by the management of chronic diseases. The study delves into the market dynamics, revealing an anticipated compound annual growth rate (CAGR) of approximately 11% from 2022 to 2028. This notable development stems from heightened governmental support and cutting-edge technological advancements fueling the demand for sophisticated patient registry solutions.

The deployment of patient registry software has become indispensable across healthcare institutions and research entities in the United States. Registries serve as a pivotal tool for collating and analyzing patient data to bolster disease management, clinical research, and policy formulation. In response to the critical need for managing chronic conditions, disease registries have emerged as the dominant segment within the market, offering unparalleled support for data-driven medical inquiries and policymaking.

Key Trends by Market Segment:

Governmental and third-party organizational applications lead in market usage, advocating for robust investment in patient registry development, infrastructure, and continuous enhancement.The Eastern USA remains prominent in the market, attributed to its densely populated urban centers and superior healthcare systems that perpetually require advanced patient registry functionalities.The accelerated focus on data interoperability and the growing inclination towards real-world evidence applications further augment the significance of patient registry software in clinical and therapeutic explorations.

Competitive Landscape:

The landscape is characterized by a mix of leading entities and emerging innovators, each contributing to the forward momentum of the market with their respective offerings. Collaborations across various sectors, including governmental, have been strategic in amplifying the effectiveness of patient registries, thus enabling the tracking and assessment of public health initiatives and research outcomes effectively.

Recent Developments:

Recent advancements in the field reflect a surge of strategic partnerships aimed at enhancing nationwide patient databases. These initiatives, ranging from specialized disease registries to collaborations with emergency medical services, showcase a nuanced approach to data utilization and insight generation.

Future Outlook:

Advancements in analytics, integration with diverse healthcare IT systems, and the incorporation of real-time data from wearable technologies herald an era of innovation in the USA Patient Registry Software market. This progress underpins the critical role patient registries have in shaping a more intelligent healthcare framework focused on evidence-based practices, ultimately leading to improved patient outcomes and optimized therapeutic interventions.

The insights revealed in this comprehensive research piece underscore the critical evolutions and future prospects of the USA Patient Registry Software market. 

Key Topics Covered:

1. Executive Summary

2. USA Patient Registry Software Market Overview
2.1 Taxonomy of the USA Patient Registry Software Market
2.2 Industry Value Chain
2.3 Ecosystem
2.4 Government Regulations/Initiatives for the USA Patient Registry Software Market
2.5 Growth Drivers of the USA Patient Registry Software Market
2.6 Issues and Challenges of the USA Patient Registry Software Market
2.7 Impact of COVID-19 on the USA Patient Registry Software Market
2.8 SWOT Analysis

3. USA Patient Registry Software Market Size, 2017-2022

4. USA Patient Registry Software Market Segmentation
4.1 By Type of Registry, 2017-2022
4.2 By Application, 2017-2022
4.3 By Regional Split (North/East/West/South), 2017-2022

5. Competitive Landscape
5.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
5.2 Strategies Adopted by Leading Players
5.3 Company Profiles – (Top 5 – 7 Major Players)

IQVIAOptum (UnitedHealth Group)PhytelDacima SoftwareFIGmdSyapsePharos Innovations

6. USA Patient Registry Software Future Market Size, 2022-2028

7. USA Patient Registry Software Future Market Segmentation
7.1 By Type of Registry, 2022-2028
7.2 By Application, 2022-2028
7.3 By Regional Split (North/East/West/South/Central), 2022-2028

8. Analyst Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/8ly78q

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716 

Logo – https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/disease-registry-innovations-propel-growth-in-usa-patient-registry-software-market-302078901.html

SOURCE Research and Markets

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

OceanBase Receives Honorable Mention for the Second Consecutive Year in the 2024 Gartner® Magic Quadrant™ Report

Published

on

By

SINGAPORE, Dec. 26, 2024 /PRNewswire/ — OceanBase has once again been named as Honorable Mention in the 2024 Gartner® Magic Quadrant™ for Cloud Database Management Systems (Cloud DBMS), marking the second consecutive year it has received this recognition.

OceanBase offers scalable distributed database for data-intensive transactional and real-time operational analytics workloads, with ultra-fast performance and high compatibility across major global cloud infrastructures, including Amazon Web Services, Google Cloud, Alibaba Cloud and Tencent Cloud. Operating across more than 30 regions in Asia, Europe, and America, OceanBase has already served over 2,000 customers, such as SAIC Volkswagen, DiDi Global, vivo, Pop Mart, Haidilao, Kwai, Trip.com, GCash, DANA, and PalmPay.

Over the past year, OceanBase has made significant strides in the Southeast Asian market. In December 2024, Starpay, a leading financial technology company in the Philippines, announced a partnership with OceanBase to leverage its cutting-edge distributed database solutions.

OceanBase hosted the inaugural OceanBase INFINITY tech conference in Jakarta, Indonesia in June 2024. During the event, the company announced strategic partnerships with leading local resellers to better serve customers in the Indonesian market.

According to Gartner’s latest DBMS market data in the Magic Quadrant, “the overall database management system market grew by 13.4% in 2023, reaching $103.2 billion“, up from $91 billion in 2022. The DBMS segment remains one of the fastest-growing areas within the software market, alongside analytic platforms, networking software, and supply chain management software.

In May 2024, OceanBase was also recognized as an Asia/Pacific Customers’ Choice and also named a Strong Performer in the 2024 Gartner® Peer Insights™ Voice of the Customer for Cloud DBMS report.

Gartner, Magic Quadrant for Cloud Database Management Systems, 18 December 2024

Gartner, Voice of the Customer for Cloud Database Management Systems, 24 May 2024

Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.

GARTNER, MGAGIC QUADRANT and PEER INSIGHTS are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

About OceanBase

OceanBase is a distributed database launched in 2010. It provides strong data consistency, high availability, high performance, cost efficiency, elastic scalability, and compatibility with mainstream relational databases. It handles transactional, analytical, and AI workloads through a unified data engine, enabling mission-critical applications and real-time analytics.

To learn more, please visit: https://www.oceanbase.com/

View original content:https://www.prnewswire.com/apac/news-releases/oceanbase-receives-honorable-mention-for-the-second-consecutive-year-in-the-2024-gartner-magic-quadrant-report-302339146.html

SOURCE OceanBase

Continue Reading

Technology

Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design

Published

on

By

‘Beyond Structure, Predicting Function’

SHANGHAI, Dec. 25, 2024 /PRNewswire/ — Recently, Shanghai Matwings Technology Co., Ltd. (‘Matwings’), a global leader in AI-driven protein design, announced the successful completion of Series A funding rounds, raising tens of millions of USD, led by Qiming Venture Partners.

Matwings is pioneering a new frontier in protein engineering with its proprietary AI-based general protein design platform, AccelProtein™, which directly predicts protein functionality beyond the structural data. By predicting functionality, AccelProtein™ offers a new approach for acquiring high-functioning proteins.

AccelProtein™ is built on the Pro-PRIME model, a breakthrough developed by a collaborative team led by Professor Liang Hong at Shanghai Jiao Tong University. After years of research focused on data collection, curation, and optimization, the team developed the Pro-series – an AI framework for protein design. Their work, titled “A General Temperature-Guided Language Model to Design Proteins of Enhanced Stability and Activity” was recently published in Science Advances.

A featured case of AccelProtein™’s impact is the design of a specialized Glycosyltransferase enzyme, which is used in the production of EPS-G7, a core material for pancreatitis screening. Within just 4 months, Matwings increased the enzyme’s total glycosylation activity by 7 times, enhanced product specificity from 60% to 98%, and reduced hydrolytic activity by 33%. These improvements cut down the cost of EPS-G7 by 90%.

In another application, Matwings successfully engineered a super alkali-resistant affinity ligand (a nanobody) for affinity chromatography, improving alkali resistance by 3 folds, binding capacity over 100%, and heat stability by 8℃. This innovation saved millions of USD in CMC costs for a Matwings client. Additionally, scale-up production to 5000L has been successfully completed. Such advancement enables low-cost affinity chromatography purification a viable option for a wide range of biologics, bringing more cost-effective solutions for drug production.

Since 2021, Matwings has successfully delivered over 30 protein-engineering and enzyme-mining projects either proprietary (e.g., Enterokinase, Carboxypeptidase B, KEX2 Protease, Maltogenic Amylase, Subtilisin, Protein A, PETase, T7 RNA Polymerase, and phi29 DNA Polymerase) and co-developed with our stakeholders. These projects span across various applications, including drug innovation, in vitro diagnostics, nutrition and healthcare, food and beverage, and green energy.

About Matwings

Matwings, founded in 2021 by an elite team from Shanghai Jiao Tong University, is one of the earliest companies to focus on AI protein models.

Matwings is dedicated to moving beyond directed evolution methods to design and engineer functionally optimized proteins by leveraging a proprietary, pre-trained, AI-based general protein design platform with 780 million curated full-length protein sequence data, including nearly 500 million private data.

This cutting-edge technology platform, AccelProtein™, enables us to engineer proteins and uncover or de novo design novel proteins with significantly improved properties, including stability, activity, affinity, yield, etc.

To date, Matwings has successfully engineered more than 30 proteins either proprietary or co-developed with its stakeholders, and more than 40 ongoing projects across various applications in pharmaceutical industries and synthetic biology industries, e.g.  key enzymes and proteins for CMC, innovative Biologics, synthetic biology and more.

Matwings is actively seeking global partnerships to jointly develop and commercialize new products.

Contact Information:
Email: info@matwings.com
Website: https://www.matwings.com/en/ 
Tel: +86 158 2106 5410
Paper Link: https://www.science.org/doi/10.1126/sciadv.adr2641 

View original content:https://www.prnewswire.com/news-releases/matwings-technology-raised-series-a-funding-of-tens-of-millions-usd-to-redefine-protein-design-302339150.html

SOURCE Matwings Technology

Continue Reading

Technology

Agoda Highlights Tokyo as Top Global New Year’s Eve Destination

Published

on

By

SINGAPORE, Dec. 26, 2024 /PRNewswire/ — Digital travel platform Agoda has announced Tokyo as the most popular destination for New Year’s Eve, based on accommodation searches. This marks a shift from last year when Taipei held the top spot. Following Tokyo, the list includes Bangkok, Taipei, Pattaya, and Osaka, showcasing a diverse range of preferences among travelers.

The data highlights a perpetual interest in Tokyo, a city known for its unique blend of tradition and modernity. Travelers are drawn to its vibrant celebrations, cultural experiences, and iconic landmarks. Bangkok and Taipei, too, continue to be favored destinations, offering rich cultural festivities and lively atmospheres. Pattaya and Osaka also make the list, appealing to those seeking beachside celebrations and culinary delights, respectively.

Agoda’s data reveals Tokyo’s prominence not only on a worldwide scale but also within Japan. Domestic accommodation searches have increased by 23%, with Tokyo leading as the preferred destination, followed by Osaka, Kyoto, Yokohama, and Okinawa Main Island. For Japanese traveling abroad, the destinations primarily considered are Taipei, Seoul, Bangkok, Pattaya, and Hong Kong.

Hiroto Ooka, Associate Vice President North Asia at Agoda said: “Tokyo’s rise to the top of Agoda’s New Year’s Eve destination list is a testament to the city’s global appeal. Whether you’re celebrating New Year’s Eve in Tokyo, Osaka, or anywhere else in the world, Agoda is ready to help you find the perfect spot to ring in the New Year.”

As travelers prepare for their New Year’s Eve plans, Agoda offers a comprehensive selection of over 4.5 million holiday properties, more than 130,000 flight routes, and over 300,000 activities, all available for seamless booking. Download the Agoda app for the latest deals or visit agoda.com/deals.

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/agoda-highlights-tokyo-as-top-global-new-years-eve-destination-302338856.html

SOURCE Agoda

Continue Reading

Trending